Home » Topics » Regulatory

Regulatory
RSS

FDA approves pediatric labeling of Prevacid

Aug. 9, 2002

Lescol sNDA filed for secondary prevention of cardiovascular events in angioplasty patients

Aug. 9, 2002

Risperdal Consta approved in Germany

Aug. 5, 2002

Levaquin sNDA submitted for chronic bacterial prostatitis

Aug. 1, 2002

Eligix CD8-SC Cell Separation System approved in E.U.

Aug. 1, 2002

Manufacturing approval obtained for Onoact

July 31, 2002

E.U. approval for cancer imaging agent Flucis

July 30, 2002

ADVENT trial results support expanded indications for Niaspan

July 30, 2002

New formulation of Rapamune introduced in U.K.

July 26, 2002

Eligard 22.5 mg approved for advanced prostate cancer

July 25, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...